The Effects of a Combination of TeaCrine®, Dynamine, and Caffeine in Law Enforcement
Status:
Completed
Trial end date:
2020-11-15
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, placebo-controlled, three-condition, double-blind,
between-subjects clinical trial is to determine and compare the effects of the combination of
TeaCrine®, Dynamine, and caffeine to a placebo and caffeine condition on reaction time and
target acquisition and accuracy. A secondary purpose is to observe the changes in hemodynamic
variables in response to this combination.
Phase:
Early Phase 1
Details
Lead Sponsor:
Rutgers, The State University of New Jersey University of South Carolina
Collaborators:
Compound Solutions Inc. Rutgers, The State University of New Jersey